Insider Trading Activity Quest Diagnostics Incorporated (NYSE:DGX) – Director Sold 1,304 shares of Stock

ME Staff
-
0

Insider Trading Activity For Quest Diagnostics Incorporated (NYSE:DGX)

Jeffrey M Leiden , Director of Quest Diagnostics Incorporated (NYSE:DGX) reportedly Sold 1,304 shares of the company’s stock at an average price of 108.73 for a total transaction amount of $141,783.92 SEC Form

Insider Trading History For Quest Diagnostics Incorporated (NYSE:DGX)

  • On 8/7/2012 Stephen H Rusckowski, CEO, bought 5,000 with an average share price of $59.34 per share and the total transaction amounting to $296,700.00.View SEC Filing
  • On 10/3/2012 Robert Hagemann, CFO, sold 46,667 with an average share price of $64.00 per share and the total transaction amounting to $2,986,688.00.View SEC Filing
  • On 1/17/2013 Gary M Pfeiffer, Director, sold 10,000 with an average share price of $60.00 per share and the total transaction amounting to $600,000.00.View SEC Filing
  • On 4/11/2013 John B Ziegler, Director, sold 1,470 with an average share price of $58.35 per share and the total transaction amounting to $85,774.50.View SEC Filing
  • On 5/14/2013 John C Md Baldwin, Director, sold 1,214 with an average share price of $59.41 per share and the total transaction amounting to $72,123.74.View SEC Filing
  • On 5/22/2013 John B Ziegler, Director, sold 31,362 with an average share price of $62.00 per share and the total transaction amounting to $1,944,444.00.View SEC Filing
  • On 6/18/2013 Michael E Prevoznik, SVP, sold 126,667 with an average share price of $62.64 per share and the total transaction amounting to $7,934,420.88.View SEC Filing

    • Analyst Ratings For Quest Diagnostics Incorporated (NYSE:DGX)
    These are 7 Hold Ratings, 6 Buy Ratings, 1 Strong Buy Rating .
    The current consensus rating for Quest Diagnostics Incorporated (NYSE:DGX) is Buy (Score: 2.57) with a consensus target price of $109.11 , a potential (0.74% upside)

    Analyst Ratings History For Quest Diagnostics Incorporated (NYSE:DGX)

    • On 10/16/2015 Wells Fargo & Company Upgraded rating Underperform to Market Perform
    • On 1/29/2016 William Blair Reiterated Rating Hold
    • On 4/22/2016 Royal Bank Of Canada Boost Price Target of rating Sector Perform with a price target of $70.00 to $76.00
    • On 5/16/2016 Robert W. Baird Reiterated Rating Hold
    • On 5/22/2016 KeyCorp Reiterated Rating Hold
    • On 6/7/2016 Morgan Stanley Reiterated Rating Sell
    • On 6/24/2016 Jyske Bank Downgraded rating Neutral to Sell

    Dividend Information For Quest Diagnostics Incorporated (NYSE:DGX)
    Quest Diagnostics Incorporated (NYSE:DGX) pays an annual dividend of Community Ranking: with a yield of 1.66% and an average dividend growth of 9.60% (3 Year Average).

    Dividend History For Quest Diagnostics Incorporated (NYSE:DGX)

  • On 2/26/2013 Quest Diagnostics Incorporated announced a quarterly dividend of $0.30 2.14% with an ex dividend date of 3/28/2013 which will be payable on 4/16/2013.
  • On 5/21/2013 Quest Diagnostics Incorporated announced a quarterly dividend of $0.30 1.96% with an ex dividend date of 6/28/2013 which will be payable on 7/17/2013.
  • On 8/20/2013 Quest Diagnostics Incorporated announced a quarterly dividend of $0.30 2.03% with an ex dividend date of 9/27/2013 which will be payable on 10/16/2013.
  • On 12/6/2013 Quest Diagnostics Incorporated announced a quarterly dividend of $0.30 1.99% with an ex dividend date of 1/3/2014 which will be payable on 1/22/2014.
  • On 1/30/2014 Quest Diagnostics Incorporated announced a quarterly dividend of $0.33 2.51% with an ex dividend date of 4/4/2014 which will be payable on 4/23/2014.
  • On 5/21/2014 Quest Diagnostics Incorporated announced a quarterly dividend of $0.33 2.3% with an ex dividend date of 7/7/2014 which will be payable on 7/23/2014.
  • On 8/15/2014 Quest Diagnostics Incorporated announced a quarterly dividend of $0.33 2.14% with an ex dividend date of 10/3/2014 which will be payable on 10/22/2014.

    • Recent Trading Activity for Quest Diagnostics Incorporated (NYSE:DGX)
    Shares of Quest Diagnostics Incorporated closed the previous trading session at 108.31 down -1.20 -1.10% with 748,387 shares trading hands.